Ledger.Open graph →
SEC Form D · filed October 2, 2012

SELEXYS PHARMACEUTICALS CORP

Offering
$45.7M
Sold
$34.5M
Exemption
—
Industry
Biotechnology
Location
OKLAHOMA CITY, OK
Type
—

People & firms on this filing (11)

Philip Jones, M.D · Norman, OKDirectorAlain Reinhold · Dublin, IrelandDirectorDavid Falconer · Edmond, OKExecJurg Schappi · Dublin, IrelandExecNicolas Motelay · Dublin, IrelandDirectorAleem Mawji · Stamford, CTExec · DirectorRandy Maksymowich · Calgary, Alberta, CanadaExec · DirectorMark Poelzer · Calgary, Alberta, CanadaExec · DirectorKevin Collings · Calgary, Alberta, CanadaExecJames Davis · Calgary, Alberta, CanadaDirectorPaul M. Britton · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗